assay development
Natera is seeking a Senior Commercialization Process Engineer to serve as the critical bridge between assay development and scalable lab production. This bench-level role is embedded early in the NPI process, working alongside Molecular Assay Development, Bioinformatics, Engineering, and Lab Operations teams to ensure that new oncology products are designed for production from day one, not retrofitted for scale after launch.
This is not a steady-state production role. This person thrives in the ambiguous, fast-moving space between R&D and operations, identifying workflow gaps, bridging informatics and lab systems, and ensuring that what gets built can be run at commercial scale reliably and repeatably.
PRIMARY RESPONSIBILITIES
- Embed within New Product Introduction (NPI) programs from feasibility through design transfer, providing bench-level lab operations perspective on workflow design, automation feasibility, and scalability requirements
- Partner with Molecular Assay Development, Pathology, Automation, Software Engineering, and other teams to evaluate molecular workflows (WES, WGS, RNA-Seq) and tissue-based workflows (histology, H&E, IHC) for operational readiness, identifying design decisions across multiple disciplines that could create production risk or technical debt prior to launch.
- Serve as the Lab Ops liaison to informatics and LIMS teams, ensuring software systems, sample tracking, and data pipelines are production-ready and validated before Process Validation begins
- Perform hands-on and modeling workflow assessments, identifying bottlenecks, manual step